Onco-cardiology: Drug-drug interactions of antineoplastic and cardiovascular drugs.

Crit Rev Oncol Hematol

Ankara University School of Medicine; Department of Medical Oncology, Ankara, Turkey; Ankara University Cancer Research Institute, Ankara, Turkey. Electronic address:

Published: January 2020

Cardiovascular diseases (CVD) and cancer are still the leading causes of death. There are many common etiologic factors, especially smoking and obesity. Therefore, it is not uncommon for CVD and cancer to coexist. Drug-drug interactions (DDIs) inevitably occur in this group of patients, where polypharmacy is increasing due to older age and multiple comorbidities. However, multidisciplinary studies, especially close collaboration of medical oncologists and cardiologists, who deals with the diagnosis and treatment of these diseases, awareness and preventive approaches to DDIs may reduce serious morbidity and mortality. In this review, information about the common treatments used in cardiology and oncology and possible DDIs are discussed.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2019.102822DOI Listing

Publication Analysis

Top Keywords

drug-drug interactions
8
cvd cancer
8
onco-cardiology drug-drug
4
interactions antineoplastic
4
antineoplastic cardiovascular
4
cardiovascular drugs
4
drugs cardiovascular
4
cardiovascular diseases
4
diseases cvd
4
cancer leading
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!